2L4O

Solution structure of the Streptococcus pneumoniae RrgB pilus backbone D1 domain

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	0.9 mM PROTEIN-2	90% H2O/10% D2O		7.2	ambient	298
2	2D 1H-1H TOCSY	0.9 mM PROTEIN-2	90% H2O/10% D2O		7.2	ambient	298
3	2D 1H-15N HSQC	0.5 mM [U-95% 15N] PROTEIN-1	90% H2O/10% D2O		7.2	ambient	298
4	2D 1H-13C HSQC	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
5	3D HN(COCA)CB	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
6	3D HNCACB	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
7	3D HNCO	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
8	3D HN(CO)CA	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
9	3D HBHA(CO)NH	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
10	3D HNCA	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
11	3D HNCACO	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
12	3D HCCH-TOCSY	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298
13	3D 1H-15N NOESY	0.5 mM [U-95% 15N] PROTEIN-1	90% H2O/10% D2O		7.2	ambient	298
14	3D 1H-13C NOESY	0.4 mM [U-95% 13C; U-95% 15N] PROTEIN-3	90% H2O/10% D2O		7.2	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	AVANCE	700
3	Bruker	AVANCE	800
4	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
simulated annealing, torsion angle dynamics	The structures were based on a total of 3131 distance constraints and 234 dihedral angle restraints, 400 random conformers were annealed in 8000 steps	CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	400
Conformers Submitted Total Number	20
Representative Model	1 (cing analysis)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	refinement	Amber	10	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo and Kollm
3	processing	TopSpin	2.0	Bruker Biospin
4	data analysis	CARA	2.0	Keller and Wuthrich
5	data analysis	XEASY		Bartels et al.
6	structure validation	CING		Geerten W. Vuister , Jurgen F. Doreleijers and Alan Wilter Sousa da Silva
7	data analysis	MOLMOL		Koradi, Billeter and Wuthrich
8	collection	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.